Lipum makes a share issue for faster progress

Being a European Commission Horizon 2020 beneficiary has a distinct positive impact on our development. The 2.2 M€ grant enables us to proceed faster towards a new drug against chronic inflammatory diseases. To further increase the momentum we are now raising additional funding by a share issue. Interested investors get a chance to join the exciting progress.

Like to learn more? »

wpadmin2019-01-25T13:47:55+01:00

This website uses cookies and embedded services from third parties. To change the settings and see more detailed information see our Settings Allow all cookies

Third Party Embeds

This website uses cookies and third party services. These features include embedding content such as videos or sharing website content on social media platforms. You can approve by clicking on the content that you allow to be displayed. Then save by clicking Update Settings.

Vimeo
Facebook
Twitter

Tracking Cookies

These cookies store information such as the number of visitors to the website, the number of unique visitors, which pages on the website have been visited, the source of the visit, etc. This data helps us to understand and analyze how well the website works. and where it needs to be improved.

Privacy Policy

From 25 May 2018, the General Data Protection Regulation (GDPR) applies as law in all EU member states.

Read our Privacy Policy

Contact Information

Contact us at info@lipum.se if you have questions about how your personal data is processed by us, or if you wish us to change / delete your personal data.